Further studies should be warranted to explore the possible HC-HMGB1-stablizingtherapeutic strategies for preventing the hepatic fat accumulation in early cases of NAFLD by way of regulating ER stress and FA β-oxidation. Here, HMGB1 is linked to metabolic dysfunction-associated steatotic liver disease.